TriALS: Triphasic-Aided Liver Lesion Segmentation Benchmark in Non-Contrast CT
Authors: Marawan Elbatel, Mohamed Ghonim, Jiaji Mao, Zhuosheng Lin, Katharina Eckstein, Andrés Martínez Mora, Jonathan Deissler, Maximilian Rokuss, +57 more
Abstract
Automated segmentation of liver lesions on non-contrast computed tomography (NCCT) is clinically important but fundamentally challenging, particularly in low-resource settings across Africa and Asia where contrast agents are frequently unavailable. Progress has been limited by the absence of annotated NCCT benchmarks. Here we describe the TriALS challenge for automated liver lesion segmentation under contrast-limited conditions, supported by a multi-centre dataset of 150 cases with four-phase CT acquisitions (600 volumes) from Egyptian and Chinese institutions. Algorithms were evaluated on 70 cases from three institutions, including an independent external cohort. The top-performing method achieved a mean venous-phase Dice of 0.754, consistent with human-level performance, yet dropped to 0.57 on NCCT. On external validation, the leading method outperformed off-the-shelf models by up to 28% in Dice on NCCT. Algorithm performance was most strongly predicted by training data scale and pre-training strategy. A cross-year comparison exposed a persistent perceptual barrier on NCCT that scaling pre-training alone cannot overcome. Data, annotations, and code are available at https://github.com/xmed-lab/TriALS.
Accurate segmentation of hepatic and portal vessels in contrast-enhanced computed tomography angiography (CTA) remains challenging due to complex vascular topology, peripheral visibility limitations, and acquisition-induced ambiguities. While existing public datasets offer valuable benchmarks, few include clinically realistic annotation constraints. We introduce VEELA (Vessel Extraction and Extrication for Liver Analysis), a rigorously curated liver vessel dataset derived from 40 CTA scans inherited from the CHAOS grand-challenge cohort. All vessels were manually delineated slice-by-slice under multi-expert consensus, using a strict visibility-driven annotation policy and avoiding anatomically inferred interpolation. This design explicitly captures anatomical variability and imaging-related uncertainty. As a continuation of the CHAOS challenge, VEELA enables reproducible cross-benchmark evaluation while extending the scope to fine-grained hepatic and portal vessel segmentation. We further establish a standardized benchmarking framework and analyze complementary evaluation metrics, including topology-aware (clDice), overlap-based (IoU), boundary-sensitive (NSD), and geometry-aware (area, length) measures. Our results demonstrate that different metrics capture distinct aspects of vascular integrity, underscoring the necessity of multi-perspective evaluation for clinically meaningful vessel segmentation. VEELA is publicly released to facilitate reproducible research and support the development of robust vascular segmentation methods. Researchers can access the evaluation metrics, dataset, and submission platform at https://www.synapse.org/Synapse:syn65471967.
Liver cancer, especially hepatocellular carcinoma (HCC), imposes a substantial global disease burden. Accurate diagnosis and prognostic assessment directly influence treatment selection and patient survival, and pathological examination remains the gold standard for liver cancer diagnosis. Identifying diverse tissue components and pathological subtypes on histopathology slides is crucial for estimating postoperative recurrence risk and overall prognosis. However, most publicly available resources are still provided at the whole-slide image (WSI) level, and well-annotated datasets for fine-grained tissue component identification in liver cancer are scarce, which hinders reproducible model development and the deployment of quantitative analysis tools. To address this gap, we release HepatoBench, a patch-level image database for liver cancer with annotations for seven key tissue categories. Based on HepatoBench, we train and open-source a deep learning classification model as a tissue recognition tool. Furthermore, we train a WSI-level tumor/non-tumor segmentation model to automatically localize lesion regions across entire slides. By integrating the patch-level tissue classifier with the WSI-level segmentation model, we build HepatoQuant, an end-to-end, disease-specific regional quantification tool for liver cancer, enabling a unified workflow from WSIs to tissue composition parsing and quantitative statistics. We also open-source HepatoBench, the benchmarking protocol, and supporting tools, providing a solid foundation for automated regional quantification and fair method comparison in liver cancer pathology.
Accurate segmentation of colorectal liver metastases (CRLM) in contrast-enhanced computed tomography (CT) is important for response assessment, surgical planning, and follow-up. We propose two parameter-efficient spectral adapters for the Segment Anything Model (SAM): the Directional Spectral Adapter (DiSECT) and Spectral Instance-Guided Adapter (SiGA). DiSECT uses singular value decomposition of frozen weights to constrain residual updates to leading spectral directions, while SiGA adds global and input-conditioned gating through a multilayer perceptron. We evaluate these methods on 446 contrast-enhanced CT volumes (355 training, 91 testing) and compare them with LoRA, QLoRA, convolutional adapters (CAD), and a 3D nnU-Net baseline. Experiments consider single-point, three-point, bounding-box, and no-prompt regimes. SiGA achieves the best single-point performance with a Dice score of 0.77, IoU of 0.69, and HD95 of 35.39 mm. Under no-prompt inference, SiGA reaches 0.76 Dice, 0.68 IoU, and 46.76 mm HD95, comparable to the nnU-Net baseline (0.758 Dice). DiSECT uses only 0.14 million trainable parameters. These results show that spectral adapters can efficiently adapt SAM for CRLM segmentation while retaining strong accuracy with limited trainable parameters.
Ramtin Mojtahedi, Mohammad Hamghalam, Jacob J. Peoples +6